尼莫通治疗脑出血的初步研究

• 作 者: 赵向东 丁树林 何龙锦 陈孝健
• 机 构: 江苏省泰兴市人民医院神经内科!泰兴225400,江苏省泰兴市人民医院神经内科!泰兴225400,江苏省泰兴市人民医院神经内科!泰兴225400,江苏省泰兴市人民医院神经内科!泰兴225400
• 出 处: 河南实用神经疾病杂志
• 发表日期: 1999年02期
• 关键词: 尼莫通 显效率 脑内血肿 常规疗法 继发性脑室出血 静脉滴注 脑水肿 生活能力状态 再出血 缺血性脑损害

76例脑出血患者使用尼莫通静脉滴注治疗，其疗效与对照组的62例采用常规疗法的脑出血患者作比较，结果显示：治疗组的显效率为73.7％，对照组为37.1％，两组有非常显著的差异（x2＝21．3，P＜0．001）；治疗组1月内脑内血肿全部吸收率为54．8％，而对照组为21．9％，有非常显著的差异（x2＝8．15，P＜0．01）。研究说明，尼莫通治疗脑出血的疗效优于常规疗法，本文对其机理作了初步探讨。

76 patients with intracerebral hemorrhage were treated with nimotop intravenous drip. The curative effect was compared with that of 62 patients in the control group who received conventional therapy. The results showed that the effective rate was 73.7% in the treatment group and 37.1% in the control group, There was a significant difference between the two groups (x2 = 21.3, P <0.001). The intracerebral hematoma absorption rate in the treatment group was 54.8% in January, compared with 21.9% in the control group, which was significant (X2 = 8.15, P <0.01). Research shows that the effect of nimotong treatment of cerebral hemorrhage than conventional therapy, the paper made a preliminary study of its mechanism.